DataLookout Blog

Weekly intelligence on clinical trial activity, competitive moves, and pipeline trends. All data sourced from ClinicalTrials.gov.

All posts

We Can Now Show You Which Trials Are at Risk
Crohn's and Colitis: The $18 Billion Bet on One New Drug Target
The MASH Pipeline in 2026: Two Approvals, $8 Billion in M&A, and 16 Phase 3 Trials
1,283 Trials, Three Arms Races: The Lung Cancer Pipeline Right Now
The Alzheimer's Pipeline After Semaglutide: Who's Still in the Race
The Obesity Pipeline Has 951 Trials and One Clear Leader
83 New Sponsor Entrants This Week: Who Just Entered Your Disease Area?
Stop Manually Checking ClinicalTrials.gov